Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Motilal Oswal ChrysCapital Drive USD 153 million Secondary Fundraising in Healthkart

    Motilal Oswal, ChrysCapital Drive $153 million Secondary Fundraising in Healthkart


    Finance Outlook India Team | Tuesday, 19 November 2024

    ChrysCapital and Motilal Oswal Alternates led a $153 million fundraising round in Healthkart, a health supplement firm where early backer Peak XV Partners exited completely.

    The fundraise included Rs 55 crore in employee stock option plans (Esops), which was Healthkart's first such exercise, according to a statement.

    Neo Group and Healthkart's previous investor, A91 Partners, also took part in the round, according to the announcement.

    Separately, two people familiar with the transaction claimed Peak XV Partners, which had invested approximately $15 million (adjusted for currency rate) in Healthkart over many stages, generated $120 million in total returns, or more than a $100 million windfall.

    Peak XV Partners owned approximately 27% of Healthkart, which was spun off in 2015 from 1mg and is now controlled by Tata Digital.

    Healthkart's current funding round valued company at $500 million, up from $370 million in December 2022, when it raised $135 million from Singapore's government wealth fund /Temasek.

    Prashant Tandon and Sameer Maheshwari launched the company in 2011.

    "We welcome ChrysCapital and Motilal Oswal to Healthkart and hope to leverage their expertise during the next phase of growth," said Maheshwari, Healthkart's founder and CEO. "Very excited about our first Esop buyback programme, which will create meaningful value for people who have played a critical role in building Healthkart."

    Healthkart's recent funding round joins a string of big secondary transactions in fast-growing firms on the route to profitability, including Lenskart, Purplle, OfBusiness, and others.

    Healthkart owns several digital-first nutrition products, including MuscleBlaze, HKVitals, and Gritzo. In FY24, the company exceeded the Rs 1,000 crore revenue mark while also achieving full-year Ebitda profitability.

    According to a statement from HealthKart, the company is continuing to enhance existing core brands while expanding into international markets. It has more than 200 outlets in 90 locations across India.

    "The Indian sports nutrition market, currently underpenetrated, is expected to expand due to a rise in fitness awareness and the increasing importance of nutrition and protein," stated Arpit Vinayak, VP at ChrysCapital



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25